|
|
Volumn 33, Issue 6, 1998, Pages 567-571
|
|
Incidence and characteristics of antiandrogen withdrawal syndrome in prostate cancer after treatment with chlormadinone acetate
a
|
|
Author keywords
Antiandrogen withdrawal syndrome; Antiandrogens; Chlormadinone acetate; Endocrine therapy; Prostate specific antigen; Prostatic neoplasms
|
|
Indexed keywords
ANTIANDROGEN;
CHLORMADINONE;
ESTRAMUSTINE PHOSPHATE;
ETHINYLESTRADIOL;
PROSTATE SPECIFIC ANTIGEN;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CASTRATION;
DRUG WITHDRAWAL;
HORMONAL THERAPY;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
PRIORITY JOURNAL;
PROSTATE TUMOR;
WITHDRAWAL SYNDROME;
AGED;
AGED, 80 AND OVER;
ANDROGEN ANTAGONISTS;
CHLORMADINONE ACETATE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
ORCHIECTOMY;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
SUBSTANCE WITHDRAWAL SYNDROME;
TREATMENT OUTCOME;
|
|
EID: 0031749852
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019657 Document Type: Article |
|
Times cited : (23)
|
|
References (23)
|
